These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 2350628

  • 1. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients.
    Katsanis E, Shapiro RS, Robison LL, Haake RJ, Kim T, Pescovitz OH, Ramsay NK.
    Bone Marrow Transplant; 1990 May; 5(5):335-40. PubMed ID: 2350628
    [Abstract] [Full Text] [Related]

  • 2. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation.
    Boulad F, Bromley M, Black P, Heller G, Sarafoglou K, Gillio A, Papadopoulos E, Sklar C.
    Bone Marrow Transplant; 1995 Jan; 15(1):71-6. PubMed ID: 7742758
    [Abstract] [Full Text] [Related]

  • 3. Growth in children following irradiation for bone marrow transplantation.
    Bushhouse S, Ramsay NK, Pescovitz OH, Kim T, Robison LL.
    Am J Pediatr Hematol Oncol; 1989 Jan; 11(2):134-40. PubMed ID: 2665547
    [Abstract] [Full Text] [Related]

  • 4. Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning.
    Slatter MA, Gennery AR, Cheetham TD, Bhattacharya A, Crooks BN, Flood TJ, Cant AJ, Abinun M.
    Bone Marrow Transplant; 2004 May; 33(9):949-53. PubMed ID: 15004542
    [Abstract] [Full Text] [Related]

  • 5. [Treatment results of bone marrow transplantation in Kyushu Cancer Center. Bone Marrow Transplantation Team].
    Tasaka H, Ikuno Y, Okamura J.
    Rinsho Ketsueki; 1990 Mar; 31(3):315-9. PubMed ID: 2366334
    [Abstract] [Full Text] [Related]

  • 6. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center.
    Gaziev D, Giardini C, Galimberti M, Lucarelli G, Angelucci E, Polchi P, Baronciani D, Erer B, Sotti G.
    Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362
    [Abstract] [Full Text] [Related]

  • 7. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.
    Berger C, Le-Gallo B, Donadieu J, Richard O, Devergie A, Galambrun C, Bordigoni P, Vilmer E, Plouvier E, Perel Y, Michel G, Stephan JL.
    Bone Marrow Transplant; 2005 May; 35(10):991-5. PubMed ID: 15806126
    [Abstract] [Full Text] [Related]

  • 8. Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome.
    Rubin CM, Mick R, Johnson FL.
    Bone Marrow Transplant; 1996 Sep; 18(3):533-40. PubMed ID: 8879614
    [Abstract] [Full Text] [Related]

  • 9. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y, Ozsahin M, Rio B, Laporte JP, Leblond V, Pène F, Laugier A.
    Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 11. Fractionated total body irradiation plus high-dose VP-16 prior to allogeneic bone marrow transplantation in children with poor risk acute leukaemias.
    Suttorp M, Schmitz N, Leuschner S, Appelt M, Rister M, Schaub J.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():144-8. PubMed ID: 2697428
    [Abstract] [Full Text] [Related]

  • 12. Thyroid function in children after allogeneic bone marrow transplantation.
    Borgström B, Bolme P.
    Bone Marrow Transplant; 1994 Jan; 13(1):59-64. PubMed ID: 8019454
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
    Inagaki J, Nagatoshi Y, Kawano Y, Saito Y, Takahashi D, Nagayama J, Shinkoda Y, Hirata H, Okamura J.
    Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
    Hernández-Boluda JC, Marín P, Carreras E, Aguilar JL, Grañena A, Rozman C, Montserrat E.
    Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
    [Abstract] [Full Text] [Related]

  • 15. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
    Kauppila M, Koskinen P, Irjala K, Remes K, Viikari J.
    Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T, Kojima S, Kato K.
    Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
    Cuthbert RJ, Shepherd JD, Nantel SH, Barnett MJ, Reece DE, Klingemann HG, Chan KW, Spinelli JJ, Sutherland HJ, Phillips GL.
    Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A, Sugimoto K, Oba T, Terakura S, Atsuta Y, Murata M, Ito M, Kodera Y, Miyamura K.
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [Abstract] [Full Text] [Related]

  • 19. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants.
    Al-Fiar FZ, Colwill R, Lipton JH, Fyles G, Spaner D, Messner H.
    Bone Marrow Transplant; 1997 May; 19(10):1019-22. PubMed ID: 9169646
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G.
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.